medline.ch Respirationstrakt Neoplasie

	Neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced non-small cell lung cancer: case series and literature review. World J Surg Oncol Yin C, Hu B, Yang X, Kou L, Tian B, Wang C, Li S, Liu B, Ge J. PMID: 37749594 [PubMed - as supplied by publisher]
	Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L). BMC Cancer Wakuda K, Kenmotsu H, Sato Y, Nakamura A, Akamatsu H, Tachihara M, Miura S, Yokoyama T, Mori K, Nakagawa K, Yamamoto N. PMID: 37749521 [PubMed - in process]
	Stereotactic Body Radiotherapy for Management of Pulmonary Oligometastases in Stage IV Colorectal Cancer: A Perspective. Clin Colorectal Cancer Fu MX, Carvalho C, Milan-Chhatrisha B, Gadi N. PMID: 37748936 [PubMed - as supplied by publisher]
	Avelumab vs platinum-based doublet chemotherapy as first-line treatment for patients with high-expression PD-L1+ metastatic non-small cell lung cancer: primary analysis from the phase 3 JAVELIN Lung 100 trial. J Thorac Oncol Reck M, Barlesi F, Chih-Hsin Yang J, Westeel V, Felip E, Özgüro, Cobo Dols M, Sullivan R, Kowalski DM, Andric Z, Ho Lee D, Sezer A, Hu P, Wang X, von Heydebreck A, Jacob N, Tadjalli Mehr K, Park K. PMID: 37748693 [PubMed - as supplied by publisher]
	A Shift in Paradigm: Selective Lymph Node Dissection for Minimizing Oversurgery in Early-Stage Lung Cancer. J Thorac Oncol Jiang C, Zhang Y, Fu F, Deng P, Chen H. PMID: 37748691 [PubMed - as supplied by publisher]
	The relationship of body mass index to setup errors, dosimetric parameters and incidence of radiation pneumonitis in non-small cell lung cancer patients undergo intensity-modulated radiation therapy: a single center observational study. Int J Radiat Biol Rao X, Liu H, Zhang Y, Xie Y, Wang G, Zhang S, Wu G, Wang Y, Zhou R. PMID: 37747796 [PubMed - as supplied by publisher]
	SIRT3 Regulates the ROS-FPR1/HIF-1Î± Axis under Hypoxic Conditions to Influence Lung Cancer Progression. Cell Biochem Biophys Huang B, Ding J, Guo H, Wang H, Xu J, Zheng Q, Zhou L. PMID: 37747648 [PubMed - as supplied by publisher]
	Psychobiological stress response to a lung cancer diagnosis: a prospective study of patients in Iceland and Sweden. Acta Oncol Hardardottir H, Aspelund T, Fall K, Broström E, Sigurdsson BB, Cook E, Valdimarsdottir H, Fang F, Sloan EK, Lutgendorf SK, Jansson C, Valdimarsdottir UA. PMID: 37747345 [PubMed - as supplied by publisher]
	Transbronchial Microwave Ablation of Peripheral Lung Tumors: The NAVABLATE Study. J Bronchology Interv Pulmonol Lau KKW, Lau RWH, Baranowski R, Krzykowski J, Ng CSH. PMID: 37747275 [PubMed - as supplied by publisher]
	Metastasis-associated lung adenocarcinoma transcript 1 molecular mechanisms in gastric cancer progression. World J Gastrointest Oncol Batista DMO, da Silva JMC, Gigek CO, Smith MAC, de Assumpção PP, Calcagno DQ. PMID: 37746646 [PubMed]
	Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma. Front Oncol Zhang T, Liu W, Xu C. PMID: 37746281 [PubMed]
	Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer. Front Oncol Liu X, Chi A. PMID: 37746276 [PubMed]
	Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications. Front Oncol Liu Y, Ding W, Wang J, Ao X, Xue J. PMID: 37746261 [PubMed - as supplied by publisher]
	Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer. Explor Target Antitumor Ther Mahajan A, B G, Wadhwa S, Agarwal U, Baid U, Talbar S, Janu AK, Patil V, Noronha V, Mummudi N, Tibdewal A, Agarwal JP, Yadav S, Kumar Kaushal R, Puranik A, Purandare N, Prabhash K. PMID: 37745691 [PubMed - as supplied by publisher]
	Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening. Front Pharmacol Wu Y, Wang Z, Yang Y, Han C, Wang L, Kang K, Zhao A. PMID: 37745050 [PubMed]
	Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study. Front Psychol Cardellino A, Shah M, Hanlon J, Kelly K, Martin A, de Climens AR, Taiyari S, Stojadinovic A. PMID: 37744571 [PubMed - as supplied by publisher]
	Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma. Oncol Res Sun LU, Tan H, Yu T, Liang R. PMID: 37744265 [PubMed - in process]
	Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer. Technol Cancer Res Treat Lin X, Cai Y, Zong C, Chen B, Shao D, Cui H, Li Z, Xu P. PMID: 37743841 [PubMed]
	Effects of refined nursing interventions in the operating room on surgical-site wound infection in patients with lung cancer: A meta-analysis. Int Wound J Wang X, Li X, Zhang J. PMID: 37743559 [PubMed - as supplied by publisher]
	Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients. BMC Cancer Ren Q, Li Q, Shao C, Zhang P, Hu Z, Li J, Wang W, Yu Y. PMID: 37741993 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 136519

Seite 1 von 6826



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung